MatthewExlineMD

Pulmonology • Columbus, OH

Critical Care Medicine, Pleural Disease, Sleep Medicine

Professor, Internal Medicine, Ohio State University College of Medicine

Join to view full profile

Dr. Exline is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Exline's full profile

Already have an account?

Office
2050 Kenny Rd
Ste 2200
Columbus, OH 43221
Phone+1 614-293-4925

Fax+1 614-293-5503

Education & Training

Ohio State University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2006
Ohio State University HospitalResidency, Internal Medicine, 2000 - 2003
University of Nevada, Reno School of MedicineClass of 2000

Certifications & Licensure

OH State Medical License 2000 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Immune Suppression and Ventilator Associated Pneumonias Start of enrollment: 2010 Feb 01
Completed
The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study Start of enrollment: 2011 Dec 14
Completed
Phase 3
Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure Start of enrollment: 2011 Mar 10
Completed
Phase 2
Procalcitonin Antibiotic Consensus Trial (ProACT) Start of enrollment: 2014 Nov 03
Completed
Not Applicable
Pragmatic Trial Examining Oxygenation Prior to Intubation Start of enrollment: 2022 Mar 10
Completed
Not Applicable
Roles: Contact
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis Start of enrollment: 2021 Jun 29
Recruiting
Phase 3
Roles: Contact
Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) Start of enrollment: 2023 Jun 06
Recruiting
Phase 1, Phase 2
Roles: Contact
Behavioral Economic & Staffing Strategies in the ICU Start of enrollment: 2024 Jul 01
Not yet recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Association Between Neuromuscular Blocking Agents and Outcomes of Emergency Tracheal Intubation: A Secondary Analysis of Randomized Trials.
Stephanie C DeMasi, Wesley H Self, Neil R Aggarawal, Michael D April, Luke Andrea
Annals of Emergency Medicine. 2024-10-08
2 citations
Long-term outcomes after treatment of delirium during critical illness with antipsychotics (MIND-USA): a randomised, placebo-controlled, phase 3 trial.
Matthew F Mart, Leanne M Boehm, Amy L Kiehl, Michelle N Gong, Atul Malhotra
The Lancet. Respiratory Medicine. 2024-08-01
SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and random...
Sonal Pannu, Matthew C Exline, Joseph S Bednash, Joshua A Englert, Philip Diaz
Trials. 2024-05-18

Press Mentions

Greek Scientist Creates COVID Breathalyzer in the U.S.November 19th, 2021
New Breath Test Detects COVID in Just SecondsNovember 18th, 2021
Ohio State Breath Test Can Identify COVID-19 in Critically Ill PatientsNovember 9th, 2021
Join now to see all